Controlled Study of ONO-5920 in Patients With Involutional Osteoporosis in Japan

PHASE3CompletedINTERVENTIONAL
Enrollment

444

Participants

Timeline

Start Date

June 30, 2004

Conditions
Involutional Osteoporosis
Interventions
DRUG

Minodronic acid hydrate

Trial Locations (9)

Unknown

Chugoku Region Facility, Chugoku

Chubu Region Facility, Chūbu

Hokkaido Region Facility, Hokkaido

Hokuriku Region Facility, Hokuriku

Kanto Region Facility, Kanto

Kinki Region Facility, Kinki

Kyushu Region Facility, Kyushu

Shikoku Region Facility, Shikoku Region Facility

Tohoku Region Facility, Tōhoku

Sponsors
All Listed Sponsors
collaborator

Astellas Pharma Inc

INDUSTRY

lead

Ono Pharmaceutical Co. Ltd

INDUSTRY

NCT00212628 - Controlled Study of ONO-5920 in Patients With Involutional Osteoporosis in Japan | Biotech Hunter | Biotech Hunter